Menu
Default Alt Text

Kalpana Vanam

Senior Vice President – Regulatory Affairs

Kalpana Vanam leads the US Regulatory division at Lupin and is responsible for the Generics, Biosimilars, and Specialty portfolio.

With over 35 years of regulatory experience, she drives product innovation from inception to market launch. Her expertise spans regulatory filings, securing approvals, and bringing complex products to market across various therapeutic fields.

Prior to joining Lupin, she held leadership roles at Glenmark, Sun Pharma, Pfizer, Sandoz, and Taro.

Flower big
Smart Guide
Consent to Collection CookieTest

This website uses cookies to enhance your overall web browsing experience, provide you with ads tailored to your interests, and allow us to measure our audience and collect other analytical data about the use of our website.

By clicking "Accept All" you consent to the collection of your personal information (which may include your Consumer Health Data) through 1st and 3rd party cookies (or similar). To edit your cookie preferences, use the options below.

For more information, please visit our Privacy Statement.

Depending on where you live, you may also be able to exercise your right to opt out or withdraw your consent.Do Not Sell/Share My Personal Information.